ABM Unveils World's First Emotion Processing Unit Chip
Advanced Brain Methodologies Inc. (ABM), a division of Primary & Preventive Care Inc., has emerged from stealth mode to announce the launch of the world's first Emotion Processing Unit (EPU) chip, announced in a press release. This AI-driven neuro-chip is set to transform the fields of neuroscience, mental health, and military strategy.
The EPU chip is designed to diagnose and treat conditions such as PTSD, anxiety, and neurodegeneration, while also enhancing cognitive adaptability in high-stress environments. ABM's innovation is supported by advances in artificial intelligence and quantum computing, positioning the company as a potential industry leader alongside giants like NVIDIA and OpenAI.
ABM has established collaborations with academic institutions, commercial and government contractors, and U.S. military agencies, providing opportunities for joint ventures and technology partnerships. These collaborations aim to enhance ABM's suite of technology offerings, which include the EPU-driven smart weapons for military use and the 'Train Your Brain' centers for cognitive training.
The introduction of the EPU chip marks a significant milestone in cognitive enhancement and mental health treatment, offering a non-pharmaceutical approach to addressing mental health disorders and advancing military intelligence capabilities.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Defense AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Defense
Sep 15 Xtremis Wins Defense Innovation Unit Spectrum Strike Challenge Sep 13 Anthropic Blocks Yemen Cell Using Claude Code for Missile Software Sep 10 HavocAI and CSBC Plan Autonomous Vessel Production in Taiwan Sep 9 SandboxAQ Tests Magnetic Navigation on Northrop Grumman Lumberjack Drone Sep 9 Knox Systems Launches IL5 Environment for Defense AI and SoftwareMore from Life Sciences
Sep 16 Remepy Names Eran Harary Chief Medical Officer Sep 16 MRO Acquires Vyne Medical to Expand Clinical Data Platform Sep 16 Standigm and Protai Start AI Molecular Glue Research Program Sep 16 Study Finds Most Patients Combine AI With Other Health Sources Sep 16 Scrum Alliance and Johns Hopkins Launch Healthcare AI CoursesLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
51WORLD Launches AperData and AperOne for Embodied AI
AMBR Rebrands and Launches Personal Finance AI Agent
Atman Health Wins ARPA-H Award to Build Heart Failure AI
Primemas Shows CXL Memory Products for Abaco AI System
EUCLYD Raises More Than €200 Million for AI Inference Infrastructure
Daily AI Brief: the AI news that matters, in your inbox.